← Leaderboards
Carolina B. Lopez
Icahn School Of Medicine At Mount Sinai
$11,911,530
Attributed
$13,032,497
Total exposure
10
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.8M · FY2009–25$2M$1.5M$1M$500K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$13,032,497 · 10
By mechanism
R01$9,852,367 · 4
R56$1,681,451 · 2
R21$1,333,586 · 3
R03$165,093 · 1
Top collaborators
- Siddharth Balachandran2 shared
- Ryan Langlois2 shared
Most similar at Icahn School Of Medicine At Mount Sinai
Same institution · by research overlap
- Yizhou Dong$9,119,472
- Megan Louise Shaw$7,623,476
- Jaime Lynn Hook$2,088,426
- Joshua Acklin$108,639
- Fernand Hayot$1,871,368
Others in their field
Top investigators on “Virus”
- David Heimbrook · Leidos Biomedical Research, Inc.$512,873,478
- Lawrence Corey · Fred Hutchinson Cancer Center$392,679,667
- Barton F Haynes · Duke University$328,711,626
- Dennis R. Burton · Scripps Research Institute$276,624,892
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$274,342,142
- Richard Webby · St. Jude Children'S Research Hospital$265,067,789
Research focus
VirusInfectionVirus DiseasesResponseCellsImmune ResponseSignal TransductionIn VivoViral GenomeVirus ReplicationViralPathway InteractionsCytokineInterferonsInsightSignal PathwayPathogenSendai VirusCell TypeGenerationsInvestigationProteinsInfluenzavirusMediating
Grant awards (36)
Long-term impact of persistent parainfluenza virus infection$596,115
R01 · FY2025 · AI · contact PI
Defective viral genomes in RSV pathogenesis$565,052
R01 · FY2025 · AI · contact PI
Defective viral genomes in RSV pathogenesis$574,216
R01 · FY2024 · AI · contact PI
Harnessing ZBP1-triggered cell death to enhance influenza vaccine responsiveness$833,534
R56 · FY2023 · AI
Defective viral genomes in RSV pathogenesis$582,015
R01 · FY2023 · AI · contact PI
Mechanisms of DDO Adjuvancy$460,280
R01 · FY2022 · AI · contact PI
Harnessing ZBP1-driven cell death to improve influenza vaccine efficacy$847,917
R56 · FY2021 · AI
Mechanisms of DDO Adjuvancy$483,905
R01 · FY2021 · AI · contact PI
Defective Viral genomes in RSV pathogenesis$469,467
R01 · FY2021 · AI · contact PI
Mechanisms of DDO Adjuvancy$483,905
R01 · FY2020 · AI · contact PI
Defective Viral genomes in RSV pathogenesis$309,997
R01 · FY2020 · AI · contact PI
Defective Viral genomes in RSV pathogenesis$129,013
R01 · FY2020 · AI · contact PI
Mechanisms of DDO Adjuvancy$470,508
R01 · FY2019 · AI · contact PI
Defective Viral genomes in RSV pathogenesis$453,929
R01 · FY2019 · AI · contact PI
Defective Viral genomes in RSV pathogenesis$509,168
R01 · FY2018 · AI · contact PI
Mechanisms of DDO Adjuvancy$469,510
R01 · FY2018 · AI · contact PI
Mechanism for virus persistence after acute infections$201,250
R21 · FY2018 · AI · contact PI
A novel virus-derived adjuvant$400,000
R01 · FY2017 · AI · contact PI
Mechanism for virus persistence after acute infections$241,500
R21 · FY2017 · AI · contact PI
A novel virus-derived adjuvant$400,000
R01 · FY2016 · AI · contact PI
IL-10 producing neutrophils during respiratory virus infection$200,000
R21 · FY2016 · AI · contact PI
A novel virus-derived adjuvant$400,000
R01 · FY2015 · AI · contact PI
IL-10 producing neutrophils during respiratory virus infection$240,000
R21 · FY2015 · AI · contact PI
A novel virus-derived adjuvant$400,000
R01 · FY2014 · AI · contact PI
A novel virus-derived adjuvant$451,810
R01 · FY2012 · AI · contact PI
A novel virus-derived adjuvant$434,579
R01 · FY2011 · AI · contact PI
A novel virus-derived adjuvant$18,840
R01 · FY2011 · AI · contact PI
A novel virus-derived adjuvant$363,110
R01 · FY2010 · AI · contact PI
Lung and bone marrow crosstalk during a respiratory infection$192,240
R21 · FY2010 · AI · contact PI
Initial study of the dendritic cell response to SeV DI particles$49,833
R03 · FY2010 · AI · contact PI
Initial study of the dendritic cell response to SeV DI particles$30,510
R03 · FY2010 · AI · contact PI
A novel virus-derived adjuvant$7,282
R01 · FY2010 · AI · contact PI
Lung and bone marrow crosstalk during a respiratory infection$5,229
R21 · FY2010 · AI · contact PI
A novel virus-derived adjuvant$419,666
R01 · FY2009 · AI · contact PI
Lung and bone marrow crosstalk during a respiratory infection$253,367
R21 · FY2009 · AI · contact PI
Initial study of the dendritic cell response to SeV DI particles$84,750
R03 · FY2009 · AI · contact PI